> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER Planning 101 Guidances This Year
- URL: https://www.fdaweb.com/cder-planning-101-guidances-this-year/
- Published: 2017-01-11T12:00:00.000Z
- Updated: 2026-09-14T21:59:29.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5137691

CDER has posted a [list](http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm417290.pdf?platform=hootsuite&ref=fdaweb.com) of 101 new and revised draft guidances in 16 categories it plans to publish in FY 2017\. Categories, with the number of planned guidances, are advertising (1), biopharmaceutics (3), biosimilarity (2), clinical/antimicrobial (1), clinical/medical (11), clinical pharmacology (8), clinical/statistical (3), drug safety (3), electronic submissions (4), generics (13), labeling (6), pharmaceutical quality/CMC (11), pharmaceutical quality/manufacturing standards (CGMP) (4), pharmacology/toxicology (1), procedural (28), and user fees (2).